U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151391) titled 'The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)' on Aug. 20.
Brief Summary: The purpose of this clinical trial is to learn if the drug guarana improves symptoms of fatigue in patients with neuroendocrine tumors and gynecologic cancers
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Neuroendocrine Tumors
Gynecologic Cancer
Intervention:
DRUG: Guarana
500 mg oral medication daily
DRUG: Placebo
Oral medication daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Utah
Published by HT Digital Content Services with permissio...